ENvue Medical, Inc. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $312K | ↓-29.7% | — | — | — |
| 2025-09-30 | $722K | ↑+92.0% | $510K | ↑+151.1% | -311.2% |
| 2025-06-30 | $494K | ↓-39.5% | $-4M | ↓-477.2% | -804.9% |
| 2025-03-31 | $1M | ↑+11.3% | $-2M | ↓-324.3% | -180.7% |
| 2024-12-31 | $444K | ↓-62.3% | — | — | — |
| 2024-09-30 | $376K | ↓-17.9% | $-998K | ↓-37.3% | -258.0% |
| 2024-06-30 | $817K | ↑+177.9% | $-688K | ↑+35.9% | -82.5% |
| 2024-03-31 | $921K | — | $-588K | ↓-136.8% | -61.7% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 51 quarters
margin trajectory tells the operating-leverage storyGo deeper
FEED Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyFEED Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics